To further confirm whether a cisplatin resistance caused by the NANOG-TRPV1-pEGFR axis was conserved in NANOGhigh lung or gastric cancer cells, we first tried to select NANOGhgih lung or gastric cancer cell lines, respectively. This evidence concerns the gene TRPV1 and gastric cancer.